SCHEMBL13894164

SCHEMBL13894164

NC(=O)c1cccc(NC(=O)c2ccccc2Oc2ccccc2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58
▸ KCNK3 O14649 3/20 0.57
▸ KCNK9 Q9NPC2 3/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ CTNNB1 P35222 1/20 0.56
▸ NR1H4 Q96RI1 1/20 0.55
▸ RAB9A P51151 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ NLRP3 Q96P20 1/20 0.52
▸ PLAU P00749 1/20 0.52
▸ PARP1 P09874 1/20 0.51
▸ PARP15 Q460N3 1/20 0.51
▸ PARP10 Q53GL7 1/20 0.51
▸ SIRT2 Q8IXJ6 1/20 0.51
▸ SIRT1 Q96EB6 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661640 0.91 SCN8A (0.61) RXFP1KCNK3KCNK9MEN1KMT2A
SCHEMBL13852930 0.90 PARP1 (0.53) RXFP1ALDH1A1MAPK1HSD17B10KCNK3
SCHEMBL28197272 0.90 NR1H4 (0.69) RXFP1ALDH1A1MAPK1HSD17B10KCNK3
SCHEMBL13852922 0.88 KMT2A (0.62) RXFP1ALDH1A1MAPK1HSD17B10KCNK3
SCHEMBL13852931 0.87 RXFP1 (0.62) RXFP1
SCHEMBL16266125 0.86 MEN1 (0.69) RXFP1ALDH1A1MAPK1HSD17B10KCNK3
SCHEMBL20644110 0.84 SCN8A (0.65) RXFP1KCNK3
SCHEMBL18132551 0.81 ALDH1A1 (0.65) ALDH1A1KCNK3KCNK9MEN1KMT2A
SCHEMBL30530104 0.80 KMT2A (0.53) KCNK3KCNK9MEN1KMT2A
SCHEMBL20644107 0.80 SCN8A (0.62) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212290-B1 ARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMA (US) 2014-12-03 — — EP disclosed
US-8779197-B2 Aryl amides useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-07-15 — — US disclosed
WO-2009049183-A1 ARYL AMIDES USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-04-16 — — WO disclosed
Send feedback